New OTC Single-Dose HSV-1 Cold Sore Tablet Launches in Europe
Navamedic has launched Virono®, described as the first over-the-counter single-dose tablet for recurrent cold sores (HSV-1).
The treatment uses a mucoadhesive buccal tablet with aciclovir that’s applied once at the first sign of an outbreak, aiming to simplify treatment compared to creams that require multiple daily applications.
The company plans rollout across Nordic and European markets as demand for easier HSV self-care options grows.